SAMRAT PHARMACHEM LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2024 ,inter alia, to consider and approve the Audited Standalone Financial Results of the company for the quarter and year ended March 31, 2024. The Board of Directors may consider a proposal to recommend dividend on the equity shares of the company for the financial year ended March 31, 2024.